HKUST2003_10_621x74_676339_k.gif

China Daily

News> Nation> Content
Tuesday, January 28, 2020, 20:44
China fast-tracks novel coronavirus vaccine development
By Xinhua
Tuesday, January 28, 2020, 20:44 By Xinhua

SHANGHAI - The project for the development of an mRNA vaccine targeting the novel coronavirus (2019-nCoV) has been urgently approved, said Shanghai East Hospital of Tongji University.

The vaccine will be co-developed by the hospital and Stermirna Therapeutics Co., Ltd.

READ MORE: China studying virulence and developing coronavirus vaccine

Li Hangwen, CEO of Stermirna Therapeutics, said no more than 40 days will be needed to manufacture the vaccine samples based on the new generation of mRNA technology and some preliminary procedures.

The samples will be sent for tests and brought to clinics as soon as possible.

The production cycle of traditional vaccines can be as long as five to six months, whereas the mRNA vaccine has the advantage of a shorter development and production cycle.

ALSO READ: Xi: China has capability to win battle against epidemic


Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !